Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EU Tackles Counterfeits, But Parallel Trade Poses Tough Issues

Executive Summary

Tackling counterfeit drugs is one pillar of the European Commission's package of new proposed pharmaceutical legislation. It will mean higher costs for most drug firms, while significant loopholes will remain

You may also be interested in...

German Ruling Will Prevent Original Products Being Split For Distribution

A German court ruling should protect high-cost original product drugs from being split by re-packagers and sold in smaller batches for profit.

Greece Lowers Drug Prices By Up To 27 Percent

Greece's debt woes lead to cuts in pharmaceutical prices and fears of an increase in parallel trade

Firms May Offer Drug Info To Patients In Europe, But To Satisfy Consumer Rights

Patient rights to access information on prescription drugs could mean that industry should be permitted to provide data, says a draft EU report.

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts